RITONAVIR | N020945 | ABBVIE INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Matrix Laboratories, Inc. - Citizen Petition FDA-2007-P-0483 Matrix Laboratories Limited, India submitted a petition under Section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA determine Ritonavir Tablets, 100 mg are suitable for submission as an Abbreviated New Drug Application, with the reference listed drug being NORVIR c | Other | 2008-06-17 | Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.